The Global Metabolomics Market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, availability of government and private funding for metabolomics research, and ongoing innovations in metabolomics instruments are driving the growth of the global metabolomics industry. Key Players: Waters Corporation (US), Agilent Technologies (US), Shim...